Literature DB >> 26793539

An Adult Paratesticular Malignant Ectomesenchymoma With Post-operative Flare-up of Lung Metastasis.

Wei-Tang Kao1, Yi-Te Chiang1, Kai-Yi Tzou1.   

Abstract

Malignant ectomesenchymoma (MEM) which is derived from the remnants of migratory neural crest cells (ectomesenchyme) is a rare and rapidly progressing tumor consisting of neuroectodermal and mesenchymal neoplastic elements. This tumor occurs mostly in children and adolescents, but rarely in adults. We report a 34-year-old male with left paratesticular malignant ectomesenchymoma who received radical orchiectomy and was followed by post-operative flare-up of lung metastasis within 2 weeks. We present the overall treatment strategies for this extremely rare tumor and related findings.

Entities:  

Keywords:  Ectomesenchymoma; Lung metastasis; Paratesticular tumor

Year:  2015        PMID: 26793539      PMCID: PMC4672669          DOI: 10.1016/j.eucr.2015.06.010

Source DB:  PubMed          Journal:  Urol Case Rep        ISSN: 2214-4420


Introduction

Malignant ectomesenchymoma (MEM) which is derived from the remnants of migratory neural crest cells (ectomesenchyme) is a rare and rapidly progressing tumor consisting of neuroectodermal and mesenchymal neoplastic elements. This tumor has been reported to occur mostly in children and adolescents, with its origin from brain, face and neck, abdomen, retroperitoneal space, pelvic cavity, perineum, scrotum, and limbs. To date, only seven scrotal malignant ectomesenchymomas have been reported. Here we report the eighth case of paratesticular malignant ectomesenchymoma and emphasize its occurrence in an adult with post-operative flare-up of lung metastasis.

Case presentation

A 34-year-old male visited our out-patient clinic with the painless left testicular mass for 1 month. Prior to this, he did not have any history of scrotal trauma, scrotal surgery, infection, and cryptorchidism. Physical examination revealed a swollen left scrotum with a painless solid mass. Ultrasound examination showed a heterogenous solid mass of 75 × 40 mm in size. The levels of lactic dehydrogenase (120 U/mL), alpha-fetoprotein (0.92 ng/mL), and beta human chorionic gonadotropin (0.19 mIU/mL) were all within normal limits. The contrast-enhanced computed tomography demonstrated the presence of a heterogenous tumor in the left scrotum area (Fig. 1). Chest x-ray showed no evidence of lung tumor. A radical orchiectomy was performed. After an uneventful post-operative period, the patient was discharged from hospital. Over a two-week post-operative follow-up, multiple lung tumors were found on chest x-ray. CT-guided lung mass biopsy was performed. The pathology revealed a metastatic malignant ectomesenchymoma that was compatible with the previous scrotum lesion. He was referred to the medical oncology department to receive further chemotherapy treatment.
Figure 1

Pelvic CT scan showing heterogenous tumor in left scrotum (arrow) and left testis (arrowhead).

Histopathological examination showed a yellowish white and elastic tumor measuring 7.5 × 4.0 × 3.6 cm in size was found to be located in the para-testicular soft tissue. The testis was not involved. The tumor had two components connecting with each other. The main component was composed of an alternating area of hypercellularity and myxoid tissues. The compact hypercellular area was composed of hyperchromatic cells with moderately pleomorphic nuclei and scattered multinucleated giant tumor cells. The myxoid area exhibited scattered spindle cells in mucoid stroma with increased mitotic activity. The other components of the tumor were composed of spindle cells with wavy nuclei arranged in loose, irregularly oriented bundles and scattered ganglion cells. Immunohistochemical staining showed the main component of the tumor cells were positive for desmin, myogenin, and myoglobin, and negative for SMA, S100, cytokeratin, EMA, synaptophysin and CD34. Thus, anaplastic embryonal rhabdomyosarcoma was considered. The other components of the tumor showed that the spindle cells were positive for S100, and negative for desmin, myoglobulin, myogenin and SMA. The ganglion cells were positive for synaptophysin. Ganglioneuroma was taken into consideration. Consequently, a malignant ectomesenchymoma was more likely based on the combined pathologic findings mentioned above (Fig. 2).
Figure 2

Histological features of MEM. A) The rhabdomyosacroma component showed alternating cellular and myxoid area, hyperchromatic cells associated with moderately pleomorphic nuclei, and scattered multinucleated tumor cells (H&E ×200). B) The ganglioneuroma component showed spindle cells with wavy nuclei arranged in loose irregularly oriented bundles with scattered ganglion cells (H&E ×200). C) The rhabdomyosacroma component was positive for Myogenin (Immunohistochemical stain for Myogenin, ×100). D) The ganglioneuroma component was positive for S100 (Immunohistochemical stain for S100 ×100).

Discussion

Malignant ectomesenchymomas (MEMs) are extremely rare tumors with about 50 cases, mostly involving children and infants, having been reported to date. Characterized by merged features of neuroectodermal and mesenchymal components, the most common neuroectodermal component is ganglioneuroblastoma, or neuroblastoma, whereas the most common mesenchymal components are embryonal rhabdomyosarcoma or other malignant mesenchymal components. Some MEMs have been diagnosed as pure rhabdomyosarcoma in the beginning. Only seven cases of MEM involving the scrotum region have been noted (Table 1)3, 11 and six of these were localized tumors followed by surgical resection and post-operative chemotherapy or radiotherapy.3, 11 The prevalence age for these seven cases ranged from 2 months to 20 year old and mostly involved infants and children below the age of three. Our patient would appear to be the eldest patient observed after a review of the related literature. MEMs usually spread en route circulation to lung or bone, or en route through the lymphatic system to retroperitoneal lymph nodes. To the best of our knowledge, our case is the first with the characteristic of flare-up of lung metastatic lesions after surgical excision of the primary tumor.
Table 1

Literature review of scrotal MEM

ReferenceYearAgeOrigin siteHistologyTreatmentFollow-up
Cozzuto et al.519823 y/oParatesticularGanglion cells, RhabdomyosarcomaS + CNo recurrence after 3 years
Kodet et al.619867 m/oParatesticularGanglioneuroma, RhabdomyosarcomaS + R + CNo recurrence after 12 years
Kasantikul et al.7198720 y/oScrotumGanglioneuroma, RhabdomyosarcomaNDND
Kilpatrick8199410 m/oScrotumMature ganglion cell, RhabdomyosarcomaNDAlive 9.5 years
Mouton et al.919967 m/oScrotumGanglion cells, Rhabdomyoblast, miscellaneous cellsS + CNo recurrence 7 months
Mouton et al.919962 m/oScrotumNeural components, miscellaneous cellsC + SNo recurrence 32 months
Edwards et al.10199913 y/oParatesticularT: Rhabodomyosarcoma, RP: Ganglion cell + RhabdomyosarcomaS + R + CRP Meta at 2 years
Present34 y/oParatesticular + Lung metaEmbryonal rhabdomyosarcoma GanglioneuromaS + CAlive 6 months

C, Chemotherapy; Meta, Metastasis; ND, No data available; R, Radiotherapy; RP, Retroperitoneum; S, Surgery; T, Testis.

Due to the rarity of these cancers, the standard therapeutic strategy that should be employed is ambiguous. To date, the most favorable therapeutic strategy for scrotal ectomesenchymoma is surgical resection to be as complete as possible and most of cases received complete tumor resection at diagnosis. Anatomically, it would be easier to perform complete resection of scrotal MEMs than other MEMs which originate from other organs and the outcomes certainly would be better. According to certain reports, chemotherapy also plays an important role in the treatment of MEMs. The fact that most mesenchymal components of ectomesenchymomas are rhabdomyosarcoma actually facilitates the selection of various chemotherapeutic agents by referring to the therapies for rhabdomyosarcoma. A poor prognosis was speculated in our case based on the prognosis-affected factors of MEM. Two considerations affect the prognosis of MEM predominately. The first point is the flare-up of lung metastasis post radical orchiectomy, which could be considered as the crucial indicator of prognosis. The second point is the age of the patient. Age factor may be also relate to survival, as patients at an age higher than 10 years old could show a worse prognosis in cases of rhabdomyosarcoma, and the prognosis of MEM is known to be worse than rhabdomyosarcoma.

Conclusion

We report a rare case of paratesticular MEMs which shows flare-up lung metastasis after radical orchiectomy.

Conflicts of interests

The authors declare they have no conflicts of interest.
  12 in total

1.  Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS).

Authors:  Tobias M Dantonello; Ivo Leuschner; Christian Vokuhl; Stefan Gfroerer; Andreas Schuck; Stefanie Kube; Michaela Nathrath; Benedikt Bernbeck; Peter Kaatsch; Niklas Pal; Gustaf Ljungman; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak
Journal:  Pediatr Blood Cancer       Date:  2012-04-25       Impact factor: 3.167

2.  Ectomesenchymoma with t(1;12)(p32;p13) evolving from embryonal rhabdomyosarcoma shows no rearrangement of ETV6.

Authors:  Sinead Howley; Deirdre Stack; Thomas Morris; Michael McDermott; Michael Capra; David Betts; Maureen J O'Sullivan
Journal:  Hum Pathol       Date:  2011-07-30       Impact factor: 3.466

3.  Rhabdomyosarcoma metastasizing as a malignant ectomesenchymoma.

Authors:  V Edwards; G Tse; J Doucet; R Pearl; M J Phillips
Journal:  Ultrastruct Pathol       Date:  1999 Jul-Aug       Impact factor: 1.094

4.  Gangliorhabdomyosarcoma: a histopathological and immunohistochemical study of three cases.

Authors:  R Kodet; N Kasthuri; H B Marsden; N A Coad; F Raafat
Journal:  Histopathology       Date:  1986-02       Impact factor: 5.087

Review 5.  Malignant ectomesenchymoma. Case report and review of the literature.

Authors:  A B Freitas; P H Aguiar; F K Miura; A Yasuda; J Soglia; F Soglia; C H Aguiar; F Vinko; N S Silva
Journal:  Pediatr Neurosurg       Date:  1999-06       Impact factor: 1.162

Review 6.  Malignant ectomesenchymoma in the wrist of a child: case report and review of the literature.

Authors:  Orit Oppenheimer; Edward Athanasian; Paul Meyers; Cristina R Antonescu; Richard Gorlick
Journal:  Int J Surg Pathol       Date:  2005-01       Impact factor: 1.271

7.  Malignant ectomesenchymoma in childhood.

Authors:  S C Mouton; H S Rosenberg; M C Cohen; R Drut; M Emms; R O Kaschula
Journal:  Pediatr Pathol Lab Med       Date:  1996 Jul-Aug

8.  Ectomesenchymoma. Report of two cases.

Authors:  C Cozzutto; A Comelli; R Bandelloni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

9.  Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis.

Authors:  S E Kilpatrick; L A Teot; K R Geisinger; P L Martin; D K Shumate; N Zbieranski; G B Russell; C D Fletcher
Journal:  Cancer       Date:  1994-12-15       Impact factor: 6.860

10.  Malignant ectomesenchymoma of the nasal cavity.

Authors:  Channappa N Patil; Sanju Cyriac; Urmila Majhi; Rejiv Rajendranath; T G Sagar
Journal:  Indian J Med Paediatr Oncol       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.